Molecular pathways of cyclic nucleotide‐induced inhibition of arterial smooth muscle cell proliferation

Cyclic adenosine 3′,5′‐monophosphate (cAMP) and cyclic guanosine 3′,5′‐monophosphate (cGMP) are second messengers involved in the intracellular signal transduction of a wide variety of extracellular stimuli. These signals regulate many biological processes including cell proliferation, differentiation, migration, and apoptosis. Recently, significant progress has been achieved in the molecular basis underlying cyclic nucleotide regulation of cell proliferation. This review summarizes our knowledge of the signaling pathways regulated by cyclic nucleotides in arterial smooth muscle cells. J. Cell. Physiol. 186:1–10, 2001. © 2001 Wiley‐Liss, Inc.

[1]  K. Fujishige,et al.  Isolation and Characterization of Two Novel Phosphodiesterase PDE11A Variants Showing Unique Structure and Tissue-specific Expression* , 2000, The Journal of Biological Chemistry.

[2]  D. Tilley,et al.  Expression of Phosphodiesterase 4D (PDE4D) Is Regulated by Both the Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinase Signaling Pathways , 2000, The Journal of Biological Chemistry.

[3]  D. Maurice,et al.  Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissues. , 2000, Molecular pharmacology.

[4]  E. Lam,et al.  Inhibition of the Phosphoinositide 3-Kinase Pathway Induces a Senescence-like Arrest Mediated by p27Kip1 * , 2000, The Journal of Biological Chemistry.

[5]  A. Wittinghofer,et al.  Mechanism of Regulation of the Epac Family of cAMP-dependent RapGEFs* , 2000, The Journal of Biological Chemistry.

[6]  T. Clemens,et al.  Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells. , 2000, American journal of physiology. Endocrinology and metabolism.

[7]  S. Jin,et al.  Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Oz,et al.  cAMP pulse during preservation inhibits the late development of cardiac isograft and allograft vasculopathy. , 2000, Circulation research.

[9]  M. Moran,et al.  The guanine nucleotide exchange factor CNrasGEF activates Ras in response to cAMP and cGMP , 2000, Current Biology.

[10]  E. Nabel,et al.  Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. , 2000, Circulation.

[11]  M. Gu,et al.  Nitric Oxide Increases p21Waf1/Cip1 Expression by a cGMP-dependent Pathway That Includes Activation of Extracellular Signal-regulated Kinase and p70 S6k * , 2000, The Journal of Biological Chemistry.

[12]  J. Baldassare,et al.  Phosphatidylinositol 3-Kinase Activity Regulates α-Thrombin-stimulated G1 Progression by Its Effect on Cyclin D1 Expression and Cyclin-dependent Kinase 4 Activity* , 2000, The Journal of Biological Chemistry.

[13]  J. Beavo,et al.  Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. , 2000, Current opinion in cell biology.

[14]  A. Toker Protein kinases as mediators of phosphoinositide 3-kinase signaling. , 2000, Molecular pharmacology.

[15]  J. Beavo,et al.  Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Omori,et al.  Binding and Phosphorylation of a Novel Male Germ Cell-specific cGMP-dependent Protein Kinase-anchoring Protein by cGMP-dependent Protein Kinase Iα* , 2000, The Journal of Biological Chemistry.

[17]  MiaofenGu,et al.  Nitric Oxide–Induced Increase in p21Sdi1/Cip1/Waf1 Expression During the Cell Cycle in Aortic Adventitial Fibroblasts , 2000 .

[18]  T. Clemens,et al.  Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells. , 2000, American journal of physiology. Endocrinology and metabolism.

[19]  M. Gu,et al.  Nitric oxide-induced increase in p21(Sdi1/Cip1/Waf1) expression during the cell cycle in aortic adventitial fibroblasts. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[20]  M. Crouch,et al.  Nitric oxide donors selectively potentiate thrombin-stimulated p70(S6k) activity and morphological changes in Swiss 3T3 cells. , 1999, Biochemical and biophysical research communications.

[21]  S. Christensen,et al.  Suppression of human inflammatory cell function by subtype‐selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B , 1999, British journal of pharmacology.

[22]  S. Fukumoto,et al.  Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. , 1999, Circulation research.

[23]  T. Lincoln,et al.  Activation of Mitogen-activated Protein Kinase Pathways by Cyclic GMP and Cyclic GMP-dependent Protein Kinase in Contractile Vascular Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.

[24]  G. Thomas,et al.  Ribosomal S6 kinase signaling and the control of translation. , 1999, Experimental cell research.

[25]  M. Waterfield,et al.  Signaling by distinct classes of phosphoinositide 3-kinases. , 1999, Experimental cell research.

[26]  T. Sasaguri,et al.  Tumor Suppressor p53 But Not cGMP Mediates NO-Induced Expression of p21Waf1/Cip1/Sdi1 in Vascular Smooth Muscle Cells , 1999 .

[27]  I. Zachary,et al.  Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells. , 1999, The Biochemical journal.

[28]  K. Bornfeldt,et al.  Cyclic Nucleotide Phosphodiesterases and Human Arterial Smooth Muscle Cell Proliferation , 1999, Thrombosis and Haemostasis.

[29]  K. Sadhu,et al.  Differential Expression of the Cyclic GMP-stimulated Phosphodiesterase PDE2A in Human Venous and Capillary Endothelial Cells , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  E. Krebs,et al.  Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. , 1999, Cellular signalling.

[31]  K. Fujishige,et al.  Cloning and Characterization of a Novel Human Phosphodiesterase That Hydrolyzes Both cAMP and cGMP (PDE10A)* , 1999, The Journal of Biological Chemistry.

[32]  P. B. Snyder,et al.  Isolation and characterization of PDE10A, a novel human 3', 5'-cyclic nucleotide phosphodiesterase. , 1999, Gene.

[33]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[34]  J. Beavo,et al.  Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Andrius Kazlauskas,et al.  PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1 , 1999, Current Biology.

[36]  M. Marletta,et al.  Guanylate cyclase and the .NO/cGMP signaling pathway. , 1999, Biochimica et biophysica acta.

[37]  P. Ruth,et al.  Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting. , 1999, Pharmacology & therapeutics.

[38]  A. Hassid,et al.  Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology. , 1999, Circulation research.

[39]  Y. Takuwa,et al.  Cyclin D1 Expression Mediated by Phosphatidylinositol 3-Kinase through mTOR-p70S6K-Independent Signaling in Growth Factor-Stimulated NIH 3T3 Fibroblasts , 1999, Molecular and Cellular Biology.

[40]  R. Busse,et al.  Growth‐inhibitory effect of cyclic GMP‐ and cyclic AMP‐dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression , 1999, British journal of pharmacology.

[41]  J. Beavo,et al.  Isolation and characterization of a dual-substrate phosphodiesterase gene family : PDE 10 A , 1999 .

[42]  J. Lawrence,et al.  Attenuation of Mammalian Target of Rapamycin Activity by Increased cAMP in 3T3-L1 Adipocytes* , 1998, The Journal of Biological Chemistry.

[43]  A M Graybiel,et al.  A family of cAMP-binding proteins that directly activate Rap1. , 1998, Science.

[44]  S. Antonarakis,et al.  Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence , 1998, Human Genetics.

[45]  A. Wittinghofer,et al.  Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP , 1998, Nature.

[46]  J. Hurley The adenylyl and guanylyl cyclase superfamily. , 1998, Current opinion in structural biology.

[47]  S. Lohmann,et al.  Cyclic-GMP-Dependent Protein Kinase Inhibits the Ras/Mitogen-Activated Protein Kinase Pathway , 1998, Molecular and Cellular Biology.

[48]  K. Ferguson,et al.  Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase. , 1998, Gene.

[49]  J. Beavo,et al.  Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[50]  K. Fujishige,et al.  Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene. , 1998, European journal of biochemistry.

[51]  R. Tuder,et al.  Role of adenylyl cyclase in proliferation of neonatal pulmonary artery smooth muscle cells. , 1998, Chest.

[52]  James F. Smith,et al.  Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase* , 1998, The Journal of Biological Chemistry.

[53]  J. Beavo,et al.  Identification and Characterization of a Novel Family of Cyclic Nucleotide Phosphodiesterases* , 1998, The Journal of Biological Chemistry.

[54]  J. Cheng,et al.  Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. , 1998, Biochemical and biophysical research communications.

[55]  V. Coghlan,et al.  Identification of cGMP-dependent protein kinase anchoring proteins (GKAPs). , 1998, Biochemical and biophysical research communications.

[56]  D. Collen,et al.  Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. , 1998, Circulation.

[57]  S. Mittnacht,et al.  Control of pRB phosphorylation. , 1998, Current opinion in genetics & development.

[58]  J. Corbin,et al.  ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. , 1998, American journal of physiology. Heart and circulatory physiology.

[59]  M. Houslay,et al.  Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. , 1997, The Biochemical journal.

[60]  E. Krebs,et al.  Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype. , 1997, The Journal of clinical investigation.

[61]  A. Takeshita,et al.  Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. , 1997, Circulation.

[62]  K. Jarnagin,et al.  Multiple splice variants of phosphodiesterase PDE4C cloned from human lung and testis. , 1997, Biochimica et biophysica acta.

[63]  U. Walter,et al.  Distinct and specific functions of cGMP-dependent protein kinases. , 1997, Trends in biochemical sciences.

[64]  P. Vadiveloo,et al.  G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2. , 1997, Atherosclerosis.

[65]  E. Duzic,et al.  Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells. , 1997, The American journal of physiology.

[66]  G. Condorelli,et al.  Activation of cAMP–PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury , 1997, Nature Medicine.

[67]  K. Ferguson,et al.  Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase. , 1997, Gene.

[68]  J. Scott,et al.  Protein Kinase A Anchoring* , 1997, The Journal of Biological Chemistry.

[69]  H. Nojima,et al.  Induction of the Cyclin-dependent Kinase Inhibitor p21Sdi1/Cip1/Waf1 by Nitric Oxide-generating Vasodilator in Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[70]  L. Hung,et al.  cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. , 1997, Circulation.

[71]  A. Hassid,et al.  NO increases protein tyrosine phosphatase activity in smooth muscle cells: relationship to antimitogenesis. , 1997, The American journal of physiology.

[72]  Y. Ishikawa,et al.  The adenylyl cyclases as integrators of transmembrane signal transduction. , 1997, Circulation research.

[73]  T. Honjo,et al.  Inhibition of Carnitine Palmitoyltransferase I Augments Sphingolipid Synthesis and Palmitate-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[74]  M. Sandrin,et al.  Switching Amino-terminal Cytoplasmic Domains of α(1,2)Fucosyltransferase and α(1,3)Galactosyltransferase Alters the Expression of H Substance and Galα(1,3)Gal* , 1996, The Journal of Biological Chemistry.

[75]  R. Buscà,et al.  Inhibition of the Phosphatidylinositol 3-Kinase/p70S6-Kinase Pathway Induces B16 Melanoma Cell Differentiation* , 1996, The Journal of Biological Chemistry.

[76]  James M. Roberts,et al.  Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors , 1996, Cell.

[77]  J. Beavo,et al.  Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[78]  F. Murad Signal Transduction Using Nitric Oxide and Cyclic Guanosine Monophosphate , 1996 .

[79]  F. Murad The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate. , 1996, JAMA.

[80]  S. Fukumoto,et al.  The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2. , 1996, Circulation research.

[81]  A. Peacock,et al.  A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells. , 1996, The Biochemical journal.

[82]  J. Pouysségur,et al.  cAMP-mediated Growth Inhibition in Fibroblasts Is Not Mediated via Mitogen-activated Protein (MAP) Kinase (ERK) Inhibition , 1996, The Journal of Biological Chemistry.

[83]  G. Muirhead,et al.  Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. , 1996, International journal of impotence research.

[84]  J. Catravas,et al.  cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue , 1996, Journal of cellular physiology.

[85]  L. Graves,et al.  Insulin, growth factors, and cAMP Antagonism in the signal transduction pathways , 1996, Trends in Endocrinology & Metabolism.

[86]  A. Hassid,et al.  Atrial and C-type natriuretic peptides amplify growth factor activity in primary aortic smooth muscle cells. , 1996, Cardiovascular research.

[87]  E. Degerman,et al.  Type III cyclic nucleotide phosphodiesterases and insulin action. , 1996, Current topics in cellular regulation.

[88]  J. Pouysségur,et al.  TGF-beta 1 and cAMP attenuate cyclin A gene transcription via a cAMP responsive element through independent pathways. , 1995, Oncogene.

[89]  J. Beavo,et al.  Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.

[90]  T. Hunter,et al.  Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. , 1995, Molecular biology of the cell.

[91]  E. Krebs,et al.  cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[92]  M. Conti,et al.  Recent progress in understanding the hormonal regulation of phosphodiesterases. , 1995, Endocrine reviews.

[93]  J. Blenis,et al.  Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP , 1995, Molecular and cellular biology.

[94]  S. M. Van Patten,et al.  Multiple pathway signal tran sduction by the cAMP‐dependent protein kinase , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[95]  M. Pierre,et al.  Inhibition of G1 cyclin expression and G1 cyclin-dependent protein kinases by cAMP in an astrocytic cell line. , 1994, Biochemical and biophysical research communications.

[96]  J. Massagué,et al.  Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27 Kip1 ) of cyclin-dependent kinase 4 activation , 1994, Cell.

[97]  E. Arnold,et al.  Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. , 1994, The American journal of physiology.

[98]  W. Kolch,et al.  Mechanism of inhibition of Raf-1 by protein kinase A , 1994, Molecular and cellular biology.

[99]  T. Bourcier,et al.  Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells. , 1994, The American journal of physiology.

[100]  B. Schaffhausen,et al.  The hunt for Ras targets , 1994, Nature.

[101]  X. F. Zhang,et al.  Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues , 1994, Molecular and cellular biology.

[102]  D. Garbers,et al.  Guanylyl cyclase receptors. , 1994, The Journal of biological chemistry.

[103]  B. Schaffhausen,et al.  Signal transduction. The hunt for Ras targets. , 1994, Nature.

[104]  S. Cook,et al.  Inhibition by cAMP of Ras-dependent activation of Raf. , 1993, Science.

[105]  P. Dent,et al.  Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate. , 1993, Science.

[106]  E. Krebs,et al.  Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[107]  J. Lawrence,et al.  Increasing cAMP attenuates activation of mitogen-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[108]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[109]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[110]  F. C. Lucibello,et al.  Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. , 1993, Journal of cell science.

[111]  M. Hallett,et al.  Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. , 1992, The Biochemical journal.

[112]  J. Nevins,et al.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[113]  N. Minamino,et al.  C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. , 1991, Biochemical and biophysical research communications.

[114]  J. Scott Cyclic nucleotide-dependent protein kinases. , 1991, Pharmacology & therapeutics.

[115]  T. Nakaki,et al.  Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. , 1990, European journal of pharmacology.

[116]  A. Newby,et al.  Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. , 1990, Atherosclerosis.

[117]  Susan S. Taylor,et al.  cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. , 1990, Annual review of biochemistry.

[118]  K. Kariya,et al.  Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. , 1989, Atherosclerosis.

[119]  A. Richards,et al.  Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. , 1989, Biochemical and biophysical research communications.

[120]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[121]  T. Lincoln,et al.  Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. , 1989, The Journal of biological chemistry.